All products are guaranteed authentic, direct from authorised distributors in Singapore.

FAMIBIOTICS FAMITOT 30 Sachets

S$130.00 (excl. GST)

FAMITOT is designed to meet the immunomodulation and brain developmental needs of young children aged 0 to 3 years old. The first 1000 days of life represent the most critical period for dietary interventions to improve children’s growth and development.

Benefits:

  • Supports Gut Immunity

The developing toddler’s gut microbiome affects metabolism, maturation of the gastrointestinal tract, immune system and brain. During the first 1000 days of life, strengthening your child’s gut immunity may determine the optimal health of the child in the rest of his or her life.

ImmuG® helps to support the gut and immune system, while Lactoferrin modulates the immune responses and promotes the growth of beneficial bifidobacteria. Lactoferrin plays a complementary role by eliminating bad bacteria and viruses. It also enhances optimal cell activity within the gut.

  • Improves Skin Health

Sensitive skin is a common issue among young children. Make sure your child’s skin health is well taken care of with ImmuG®. The well researched, clinically proven HRBs in ImmuG® are safe and certified GRAS by USFDA.”

  • Supports Brain Development

DHA is essential for brain and cognitive development during early childhood. It is also linked to better vision, and reduced inflammatory response. Combination of ImmuG®, Lactoferrin, and DHA complements each other in supporting the toddlers’ growth and development early in life.

FAMITOT contains the EFSA’s recommended daily intake of DHA for children, one of the highest recommended in the world.

  • Nature’s Alternative to Drug*

*As probiotics are not medicines meant for treatment of existing health conditions, please consult your doctor for advice if in doubt.

Description

Reference:

  1. Hojsak I. Probiotics in Children: What Is the Evidence?. Pediatr Gastroenterol Hepatol Nutr. 2017;20(3):139‐146.
  2. Patole S.et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-a randomized double blind placebo controlled trial. PLoS ONE. 2014, 9, e89511.
  3. Patole SK et al. Benefits of Bifidobacterium breve M-16V supplementation in preterm neonates-a retrospective cohort study. PLoS ONE. 2016, 11, e0150775
  4. Satoh Y et al. Bifidobacteria prevents necrotizing enterocolitis and infection in preterm infants. Int. J. Probiotics Prebiotics. 2007, 2, 49.

Title

Go to Top